Complement C3a and C5a induce different signal transduction cascades in endothelial cells

Journal of Immunology

Volumn 169, Issue 4, 2002, Pages 2102-2110

  Schraufstatter, Ingrid U ^a   Trieu, Khanh ^a   Sikora, Lyudmila ^a   Sriramarao, P ^a   DiScipio, Richard ^a  

^a LA JOLLA INSTITUTE FOR MOLECULAR MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; F ACTIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; NEUTRALIZING ANTIBODY; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; RHO FACTOR;

ARTICLE; CELL MEMBRANE PERMEABILITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LEUKOCYTE MIGRATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN BLOOD VESSEL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0037103283     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.4.2102     Document Type: Article

References (79)

1. Structure and function of the anaphylatoxins
2. Structure and function of C3a anaphylatoxins
3. Biochemistry and biology of anaphylatoxins
4. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under simulated conditions in vivo
5. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation is secondary to eosinophil activation
6. Purification and partial characterization of human and porcine C3a anaphylatoxin
7. The derivation of two distinct anaphylatoxins activities from the third and fifth comonent of complement
8. Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator
9. Cellular expression of the C5a anaphylatoxin receptor (C5aR): Demonstration of C5aR on nonmyeloid cells of the liver and the lung
10. Expression of functional receptors for C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2: Stimulation of acute phase protein-specific mRNA and protein synthesis by human anaphylatoxin
11. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes
12. Cultured human glomeruar mesangial cells express the C5a receptor
13. Expression of the anaphylatoxin C5a receptor on non-myeloid cells
14. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system
15. Signal transduction and ligand-receptor dynamics in the human neutrophil
16. Role of complement in in vitro and in vivo lung inflammatory reactions
17. Expression of a functional anaphylatoxin C3a receptor by astrocytes
18. Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells
19. C3a binds to the seven transmembrane anaphylatoxin receptor expressed by epithelial cells and triggers the production of IL-8
20. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse
21. 2+ influx in neutrophils via a pertussis toxin sensitive G protein
22. Blood- and skin-derived monocytes/macrophages respond to C3a but not C3a(desArg) with a transient release of calcium via a pertussis toxin sensitive pathway
23. Mitogen-activated protein kinase activation requires two signal inputs from the human anaphylatoxin C5a receptor
24. i in U-937 cells and in cells transfected with the C5a receptor cDNA
25. α16-mediated inositol phosphate release
26. Gα16 couples chemoattractant receptors to NF-κB activation
27. Gα16, a G protein α subunit specifically expressed in hematopoietic cells
28. The activation of human complement component C5 by a fluid phase convertase
29. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line
30. Involvement of the small GTPase rho in integrin-mediated activation of mitogen-activated protein kinase
31. An essential part for rho-associated kinase in the transcellular invasion of tumors
32. Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site
33. Discovery of a novel, potent, and src family selective tyrosine kinase inhibitor
34. IL-8 activates endothelial cell CXCR1 and CXCR2 through rho and rac signaling pathways
35. Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leukocytes form human blood by the Hypaque-Ficoll method
36. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothial migration in vitro and in vivo
37. Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN)
38. Characterization of C3a receptor-proteins on guinea-pig platelets and human polymorphonuclear leukocytes
39. Neutrophil F-actin and myosin but not microtubules functionally regulate transepithelial migration induced by interleukin 8 across a cultured intestinal epithelial monolayer
40. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors
41. i-mediated cas tyrosine phosphorylation in vascular enothelial cells stimualted with sphingosine 1-phosphate
42. Regulation of tyrosine kinase cascades by G-protein-coupled receptors
43. The EGF receptor as central transducer of heterologous signalling systems
44. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin-II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells
45. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF
46. + CXC chemokine-induced angiogenic activity
47. CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2
48. Characterization of binding sites for chemokines MCP-1 and MIP-1α on human brain microvessels
49. Release of histamine from rat mast cells by the complement peptides C3a and C5a
50. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis
51. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2)
52. Angiogenesis and G-protein-coupled receptors: Signals that bridge the gap
53. Interleukin-8 as a macrophage-derived mediator of angiogenesis
54. The reaction mechanism of human C5 in immune hemolysis
55. Anaphylatoxin inactivator of human plasma: Its isolation and characterization as a carboxypeptidase
56. Specific interactions of chemoattractant factor receptors with G-proteins
57. α16 contribute to the specificity of activation by the C5a receptor
58. α13 stimulate rho-dependent stress fiber formation and focal adhesion assembly
59. α minigenes expressing C-terminal peptides serve as specific inhibitors of thrombin-mediated endothelial activation
60. The G-protein G13 but not G12 mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to rho
61. α13 in receptor-mediated stress fiber formation
62. Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 213: Evidence that directed migration is mediated by βγ dimers released by activation of Gai-coupled receptors
63. Signal characteristics of G protein-transactivated EGF receptor
64. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
65. Tumor angiogenesis and metastasis correlation in invasive breast cancer
66. Epidermal growth factor-induced nuclear factor κB activation A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells
67. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-κB
68. Tumor necrosis factor α and interferon γ synergistically induce interleukin-8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites on the interleukin 8 gene
69. Functional role of C5a receptor expression on mouse microvascular endothelium
70. Heparin-binding EGF-like growth factor
71. Lysophosphatidylcholine transcriptionally induces growth factor expression in cultured human endothelial cells
72. Heparin-binding epidermal-growth-factor-like gene expression is induced by scrape-wounding epithelial cell monolayers: Involvement of mitogen-activated protein kinase cascades
73. The requirement of both intracellular reactive oxygen species and intracellular calcium elevation for the induction of heparin-binding EGF-like growth factor in vascular endothelial cells
74. Regulation of the actin cytoskeleton by thrombin in human endothelial cells: Role of Rho proteins in endothelial barrier function
75. G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets
76. Thrombin inactivates myosin light chain phosphatase via Rho and its target rho kinase in human endothelial cells
77. Endothelial myosin light chain kinase regulates neutrophil migration across human endothelial cell monolayer
78. Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway
79. Molecular mechanisms underlying lymphocyte recirculation. I. Functional, phenotypical and morphological characterization of high endothelial cells cultured in vitro